Showing results (791-800 of 867) with videos related to
Sort By:
Pageof 87
Journal of Breast Cancer|October 3, 2018
Evaluating the Prediction of Breast Cancer Survival Using Lymph Node RatioMan Hung, Julie Xu, Dominique Nielson, et al.Journal of Breast Cancer|October 3, 2018
The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast CancerSanrong Li, Jing Ma, Caiying Hu, et al.Journal of Breast Cancer|July 9, 2019
Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC PathwayChien-Liang Liu, Ming-Jen Chen, Jiunn-Chang Lin, et al.Journal of Breast Cancer|July 9, 2019
Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast CancerDehai Yu, Libo Shi, Yuhui Bu, et al.Journal of Breast Cancer|July 9, 2019
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast CancerYi Heng Seow, Ru Xin Wong, John Heng Chi Lim, et al.Journal of Breast Cancer|October 11, 2019
Druggable Molecular Targets for the Treatment of Triple Negative Breast CancerMaryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, et al.Journal of Breast Cancer|October 11, 2019
Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with TamoxifenSoo Yeon Baek, Ji Yeong Kwon, Young Joo Lee, et al.Journal of Breast Cancer|October 11, 2019
Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell CarcinomaJeongshin An, Youngeun Yoo, Hyun Goo Kim, et al.Journal of Breast Cancer|April 13, 2023
Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational StudySeung Mi Yeo, Ji Young Lim, Seok Won Kim, et al.Journal of Breast Cancer|April 13, 2023
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control StudyLitong Yao, Xiaoyan Liu, Mozhi Wang, et al.Pageof 87